Table II.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Prognostic features | P-value | HR (95% CI) | P-value | HR (95% CI) |
Gender | N.S.S. | 0.87 (0.63–1.41) | ||
Age, years | N.S.S. | 1.21 (0.89–4.29) | ||
WHO grade | 0.029 | 4.33 (3.89–5.40) | 0.107 | 3.58 (2.89–5.92) |
KPS | 0.241 | 1.93 (1.04–4.78) | N.S.S. | 1.28 (0.67–2.71) |
Tumor size, cm | N.S.S. | 2.04 (1.18–5.31) | ||
miR-141 expression | 0.003 | 6.73 (4.83–9.63) | 0.007 | 4.12 (3.24–6.36) |
HR, hazard ratio; CI, confidence interval; N.S.S., not statistically significant; WHO, World Health Organization; KPS, Karnofsky Performance Scale; miR, microRNA.